Risk factors and outcomes of methicillin-resistant Staphylococcus aureus bacteraemia in critically ill patients: A case control study

Anaesthesia and Intensive Care

Volumn 37, Issue 3, 2009, Pages 457-463

  Ho, K M ^a,b   Robinson, J O ^a,c  

^a ROYAL PERTH HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c CURTIN UNIVERSITY   (Australia)

Author keywords

Antibiotic resistance; Bloodstream infections; Endocarditis; Long term survival; Prognosis; Sepsis

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CRITICALLY ILL PATIENT; FEMALE; HOSPITALIZATION; HUMAN; INTENSIVE CARE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MORTALITY; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

EID: 66249136337     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: 10.1177/0310057x0903700320     Document Type: Article

References (31)

1. Skiest DJ, Brown K, Cooper TW, Hoffman-Roberts H, Mussa HR, Elliott AC. Prospective comparison of methicillin-susceptible and methicillin-resistant community-associated Staphylococcus aureus infections in hospitalized patients. J Infect 2007; 54:427-434.
2. Ho PL, for the Hong Kong intensive care unit antimicrobial resistance study (HK-ICARE) Group. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med 2003; 31:1175-1182.
3. Robinson JO, Pearson JC, Christiansen KJ, Coombs GW, Murray RJ. Community-associated versus healthcare-associated methicillin-resistant Staphylococcus aureus bacteraemia: a 10-year retrospective review. Eur J Clin Microbiol Infect Dis 2008; Oct 11:[Epub ahead of print].
4. Viallon A, Marjollet O, Berthelot P, Carricajo A, Guyomarc'h S, Robert F et al. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in patients admitted to the ED. Am J Emerg Med 2007; 25:880-886.
5. Manzur A, Vidal M, Pujol M, Cisnal M, Hornero A, Masuet C et al. Predictive factors of meticillin resistance among patients with Staphylococcus aureus bloodstream infections at hospital admission. J Hosp Infect 2007; 66:135-141.
6. Rezende NA, Blumberg HM, Metzger BS, Larsen NM, Ray SM, McGowan JE Jr. Risk factors for methicillin-resistance among patients with Staphylococcus aureus bacteremia at the time of hospital admission. Am J Med Sci 2002; 323:117-123.
7. Lin JC, Yeh KM, Peng MY, Chang FY. Community-acquired methicillin-resistant Staphylococcus aureus bacteremia in Taiwan: risk factors for acquisition, clinical features and outcome. J Microbiol Immunol Infect 2004; 37:24-28.
8. Wang FD, Chen YY, Chen TL, Liu CY. Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control 2008; 36:118-122.
9. Wang JL, Chen SY, Wang JT, Wu GH, Chiang WC, Hsueh PR et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008; 46:799-806.
10. Decker CF. Pathogenesis of MRSA infections. Dis Mon 2008; 54:774-779.
11. Shurland S, Zhan M, Bradham DD, Roghmann MC. Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:273-279. (Pubitemid 46480725)
12. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53-59.
13. Datta R, Huang SS. Risk of infection and death due to methicillin- resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008; 47:176-181.
14. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281-285.
15. Ganesan A. Methicillin-resistant Staphylococcus aureus bacteremia and pneumonia. Dis Mon 2008; 54:787-792.
16. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13:818-829. (Pubitemid 15250137)
17. Nagelkerke NJ. A note on a general definition of the coefficient of determination. Biometrika 1991; 78:691-692.
18. Ho KM, Knuiman M, Finn J, Webb SA. Estimating long-term survival of critically ill patients: the PREDICT model. PLoS oNE 2008; 3:e3226.
19. Bader MS. Staphylococcus aureus bacteremia in older adults: predictors of 7-day mortality and infection with a methicillin-resistant strain. Infect Control Hosp Epidemiol 2006; 27:1219-1225.
20. Laurent F, Lelièvre H, Cornu M, Vandenesch F, Carret G, Etienne J et al. Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 2001; 47:277-283. (Pubitemid 32229569)
21. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166-174.
22. Corriere MD, Decker CF. MRSA: an evolving pathogen. Dis Mon 2008; 54:751-755.
23. Lodise TP, McKinnon PS, Swiderski L, Rybak MJ. outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis 2003; 36:1418-1423.
24. Stamper PD, Cai M, Howard T, Speser S, Carroll KC. Clinical validation of the molecular BD Geneohm StaphSR assay for direct detection of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus in positive blood cultures. J Clin Microbiol 2007; 45:2191-2196.
25. Harbarth S, Ferrière K, Hugonnet S, Ricou B, Suter P, Pittet D. Epidemiology and prognostic determinants of bloodstream infections in surgical intensive care. Arch Surg 2002; 137:1353-1359. (Pubitemid 35429592)
26. Kim SH, Kim KH, Kim HB, Kim NJ, Kim EC, Oh MD et al. Outcome of vancomycin treatment in patients with methicillin- susceptible Staphylococcus aureus bacteremia. Antimicrob Agents Chemother 2008; 52:192-197.
27. Harbarth S, Rutschmann O, Sudre P, Pittet D. Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 1998; 158:182-189.
28. Haessler S, Mackenzie T, Kirkland KB. Long-term outcomes following infection with meticillin-resistant or meticillin-susceptible Staphylococcus aureus. J Hosp Infect 2008; 69:39-45.
29. Gleeson TD. Prevention and control of methicillin-resistant Staphylococcus aureus. Dis Mon 2008; 54:801-806.
30. Lederer SR, Riedelsdorf G, Schiffl H. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients. Eur J Med Res 2007; 12:284-288.
31. Turnidge JD, Nimmo GR, Pearson J, Gottlieb T, Collignon PJ; Australian Group on Antimicrobial Resistance. Epidemiology and outcomes for Staphylococcus aureus bacteraemia in Australian hospitals, 2005-2006: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell 2007; 31:398-403.